![Richard Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Murray
Director/Board Member at
Stellular Bio, Inc.
Profile
Richard Murray was the founder of EOS Biotechnology, Inc. founded in 1998 where he held the title of Vice President-Research until 2003.
He is currently a Director at Stellular Bio, Inc. since 2019.
Dr. Murray's former positions include Director, Chief Scientific Officer & EVP at PDL BioPharma, Inc. from 2007 to 2008, Director at Jounce Therapeutics, Inc. in 2023, Senior Vice President-Research & Development at Merck & Co., Inc. from 2009 to 2014, Chief Scientific & Technical Officer & Senior VP at Protein Design Labs, Inc. from 2003 to 2006, and Senior Staff Scientist at DNAX Research, Inc. from 1991 to 1998.
Dr. Murray's education includes an undergraduate degree from the University of Massachusetts, and doctorate degrees from The University of North Carolina at Chapel Hill and The University of North Carolina at Charlotte.
Richard Murray active positions
| Companies | Position | Start |
|---|---|---|
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Director/Board Member | 03/06/2019 |
Former positions of Richard Murray
| Companies | Position | End |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Chief Executive Officer | 30/03/2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 31/12/2013 |
| PDL BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 04/09/2008 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Chief Tech/Sci/R&D Officer | 09/01/2006 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Founder | 31/03/2003 |
Training of Richard Murray
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
DNAX Research, Inc. | |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Commercial Services |
- Stock Market
- Insiders
- Richard Murray
